234 related articles for article (PubMed ID: 11505409)
1. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival.
Kawamura T; Kusakabe T; Sugino T; Watanabe K; Fukuda T; Nashimoto A; Honma K; Suzuki T
Cancer; 2001 Aug; 92(3):634-41. PubMed ID: 11505409
[TBL] [Abstract][Full Text] [Related]
2. [Expression of glucose transporter 1 in gastric carcinoma and metastatic lymph nodes and its association with prognosis].
Wei B; Chen L; Li J
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):277-80. PubMed ID: 19434538
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
4. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis.
Hashimoto T; Kusakabe T; Sugino T; Fukuda T; Watanabe K; Sato Y; Nashimoto A; Honma K; Kimura H; Fujii H; Suzuki T
Pathobiology; 2004; 71(5):267-73. PubMed ID: 15459486
[TBL] [Abstract][Full Text] [Related]
5. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
[TBL] [Abstract][Full Text] [Related]
6. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in gastric carcinoma: relation to histological subtypes, depth of tumor invasion, and glucose transporter-1 expression.
Yamada A; Oguchi K; Fukushima M; Imai Y; Kadoya M
Ann Nucl Med; 2006 Nov; 20(9):597-604. PubMed ID: 17294670
[TBL] [Abstract][Full Text] [Related]
8. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
9. Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
Sakashita M; Aoyama N; Minami R; Maekawa S; Kuroda K; Shirasaka D; Ichihara T; Kuroda Y; Maeda S; Kasuga M
Eur J Cancer; 2001 Jan; 37(2):204-9. PubMed ID: 11166147
[TBL] [Abstract][Full Text] [Related]
10. The effect of Glut1 and c-myc on prognosis in esophageal squamous cell carcinoma of Kazakh and Han patients.
Zhou YX; Zhou KM; Liu Q; Wang H; Wang W; Shi Y; Ma YQ
Future Oncol; 2018 Aug; 14(18):1801-1815. PubMed ID: 29629851
[TBL] [Abstract][Full Text] [Related]
11. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter 1 (GLUT1) expression is associated with intestinal type of gastric carcinoma.
Kim WS; Kim YY; Jang SJ; Kimm K; Jung MH
J Korean Med Sci; 2000 Aug; 15(4):420-4. PubMed ID: 10983690
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
14. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis.
Haber RS; Rathan A; Weiser KR; Pritsker A; Itzkowitz SH; Bodian C; Slater G; Weiss A; Burstein DE
Cancer; 1998 Jul; 83(1):34-40. PubMed ID: 9655290
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
16. Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis.
Li ZR; Wang Z; Zhu BH; He YL; Peng JS; Cai SR; Ma JP; Zhan WH
Surg Today; 2007; 37(8):646-51. PubMed ID: 17643206
[TBL] [Abstract][Full Text] [Related]
17. Transketolase-Like Protein 1 and Glucose Transporter 1 in Gastric Cancer.
Ahopelto K; Laitinen A; Hagström J; Böckelman C; Haglund C
Oncology; 2020; 98(9):643-652. PubMed ID: 32434192
[TBL] [Abstract][Full Text] [Related]
18. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
[TBL] [Abstract][Full Text] [Related]
19. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Mineta H; Miura K; Takebayashi S; Misawa K; Araki K; Misawa Y; Ueda Y
Anticancer Res; 2002; 22(6B):3489-94. PubMed ID: 12552944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
